Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mechanism of Ciliary Motion01:05

Mechanism of Ciliary Motion

3.7K
The ciliary structures were first seen in 1647 by Antonie Leeuwenhoek while observing the protozoans. In lower organisms, these appendages are responsible for cell movement, while in higher organisms, these appendages help in the movement of the extracellular fluids within the body cavities.
The cilia are made up of microtubules in a 9+2 arrangement, with nine microtubule doublet ring bundles, surrounding a pair of central singlet microtubule bundles. The doublet microtubule bundles are...
3.7K
Gene Therapy00:59

Gene Therapy

25.5K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.5K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

194
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
194
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

791
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
791
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

280
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
280

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The association between chronic rhinosinusitis, bronchiectasis and type 2 inflammation: an EMBARC registry analysis.

ERJ open research·2026
Same author

Preclinical human models of primary ciliary dyskinesia.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Comorbid diabetes disease severity and microbial changes in patients with bronchiectasis: a combined analysis of data from the EMBARC, EMBARC-India, Australian, and BE-China registries.

The Lancet. Respiratory medicine·2026
Same author

Nasal nitric oxide combined with clinical features for preliminary screening of primary ciliary dyskinesia in bronchiectasis.

The European respiratory journal·2026
Same author

Frequent exacerbators and neutrophil elastase activity in bronchiectasis: a network analysis approach.

ERJ open research·2026
Same author

Azurocidin-1 as a mediator of bronchiectasis severity, epithelial defence, and target of dipeptidyl peptidase-1 inhibition: an international, multicohort study.

The Lancet. Respiratory medicine·2026

相关实验视频

Updated: Jul 18, 2025

Collection, Expansion, and Differentiation of Primary Human Nasal Epithelial Cell Models for Quantification of Cilia Beat Frequency
11:13

Collection, Expansion, and Differentiation of Primary Human Nasal Epithelial Cell Models for Quantification of Cilia Beat Frequency

Published on: November 10, 2021

4.1K

恢复纤维功能:用于原发性纤维功能障碍的基因治疗方法

Nicholas W Keiser1, Erin Cant2, Sneha Sitaraman1

  • 1Spirovant Sciences, Inc., Philadelphia, Pennsylvania, USA.

Human gene therapy
|August 25, 2023
PubMed
概括

初级状动力障碍 (PCD) 是一种影响动的遗传疾病,导致肺部疾病. 基因疗法为这种复杂的疾病提供了有前途的未来治疗方法.

关键词:
在 AAV AAV AAV 中.西里亚西里亚是什么意思基因治疗的基因疗法肺 肺 肺 肺 肺 肺 肺 肺 肺病毒载体病毒载体

更多相关视频

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia
05:32

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia

Published on: January 19, 2022

4.4K
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

4.9K

相关实验视频

Last Updated: Jul 18, 2025

Collection, Expansion, and Differentiation of Primary Human Nasal Epithelial Cell Models for Quantification of Cilia Beat Frequency
11:13

Collection, Expansion, and Differentiation of Primary Human Nasal Epithelial Cell Models for Quantification of Cilia Beat Frequency

Published on: November 10, 2021

4.1K
High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia
05:32

High-speed Video Microscopy Analysis for First-line Diagnosis of Primary Ciliary Dyskinesia

Published on: January 19, 2022

4.4K
Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

4.9K

科学领域:

  • 遗传学 是一个遗传学.
  • 肺部病理学 肺部病理学
  • 细胞生物学 细胞生物学

背景情况:

  • 初级状动力障碍 (PCD) 是一种遗传性疾病,影响状动力的功能.
  • 膜缺陷显著影响多个器官系统,特别是肺部,由于呼吸道表面防御功能受损.
  • 由于复杂的测试和与其他呼吸道疾病重叠的症状,PCD诊断存在挑战.

研究的目的:

  • 提供对初级状动力障碍 (PCD) 的综合性综述.
  • 涵盖PCD的临床表现,诊断方法,遗传基础和当前的管理策略.
  • 探索PCD模型系统和基因疗法的治疗潜力,用于毛气道细胞.

主要方法:

  • 关于原发性纤维动力障碍 (PCD) 的文献综述.
  • 分析与PCD相关的临床症状,诊断方法和遗传因素.
  • 评估现有和新兴的治疗策略,包括基因疗法.

主要成果:

  • 肺结核病是一种遗传复杂的疾病,具有多样化的临床表现,通常表现为肺部疾病.
  • 由于依赖专门测试和与其他呼吸系统疾病的表型相似性,诊断挑战仍然存在.
  • 几种基因与PCD有关,虽然没有治愈方法,但基因疗法显示出治疗的前景.

结论:

  • 初级状动力障碍 (PCD) 是一种日益公认的影响状元的遗传疾病,具有显著的呼吸道影响.
  • 有效的PCD诊断和管理需要专门的方法.
  • 基因疗法是治疗PCD的关键未来策略,通过向缺陷的状细胞来治疗PCD.